HEALY JAMES
Insider CIK 1245624 · ITMN Director · ALIM 10% owner · MRNS 10% owner · OCRX 10% owner · KBIO Director, 10% owner · ANTH Director, 10% owner · AERI 10% owner · LIFE 10% owner · TSRX 10% owner · HSGX 10% owner · HPTX Director, 10% owner · EDGE Director · PRNB 10% owner · CHRS Director · VSAR 10% owner · MIRN 10% owner · DRTX Director, 10% owner · ACRS 10% owner · GRTX 10% owner · NTRA Director · BOLT Director · CMPI 10% owner · ITRM Director, 10% owner · NXTC 10% owner · INZY 10% owner · BIOA Director · AKUS 10% owner · YMAB Director · ETTX 10% owner · KRTX Director · AVTE 10% owner · VERA 10% owner · AVBP Director · CINC Director, 10% owner · RAPP Director · SPTX Director · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-28 | 2026-10-30 | 6,933 | $21.00 | $145.6K | 25,267 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-28 | 2026-10-30 | 3,772 | $21.00 | $79.2K | 14,924 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-28 | 2026-10-30 | 6,395 | $21.00 | $134.3K | 17,990 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-28 | 2026-10-30 | 952,380 | $21.00 | $20.00M | 2,815,707 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 6,052,631 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,526,315 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 1,927,159 | — | $0 | 1,927,159 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 804,379 | — | $0 | 2,731,538 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 14,222 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 11,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 11,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 14,545 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 8,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 13,950 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 16,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 33,450 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer | 2025-09-16 | 2025-09-18 | 25,080 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 2,194,278 | $8.60 | $18.87M | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | U Tender | 2025-09-16 | 2025-09-18 | 31,603 | $8.60 | $271.8K | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2025-06-30 | 2025-07-02 | 33,450 | — | $0 | 33,450 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 25,080 | — | $0 | 56,683 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-04-25 | 2025-04-29 | 142 | — | $0 | 46,260 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2025-01-31 | 2025-02-04 | 114 | — | $0 | 46,118 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-10-25 | 2024-10-29 | 153 | — | $0 | 46,004 | SEC↗ |
| BIOA BioAge Labs, Inc. | C Conversion deriv | 2024-09-27 | 2024-09-27 | 7,310,796 | — | $0 | 0 | SEC↗ |
| BIOA BioAge Labs, Inc. | P Buy | 2024-09-27 | 2024-09-27 | 11,113 | $18.00 | $200.0K | 11,113 | SEC↗ |
| BIOA BioAge Labs, Inc. | P Buy | 2024-09-27 | 2024-09-27 | 21,814 | $18.00 | $392.7K | 21,814 | SEC↗ |
| BIOA BioAge Labs, Inc. | P Buy | 2024-09-27 | 2024-09-27 | 18,353 | $18.00 | $330.4K | 18,353 | SEC↗ |
| BIOA BioAge Labs, Inc. | P Buy | 2024-09-27 | 2024-09-27 | 26,497 | $18.00 | $476.9K | 26,497 | SEC↗ |
| BIOA BioAge Labs, Inc. | P Buy | 2024-09-27 | 2024-09-27 | 588,888 | $18.00 | $10.60M | 2,227,124 | SEC↗ |
| BIOA BioAge Labs, Inc. | C Conversion | 2024-09-27 | 2024-09-27 | 1,638,236 | — | $0 | 1,638,236 | SEC↗ |
| BIOA BioAge Labs, Inc. | A Award deriv | 2024-09-25 | 2024-09-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-07-26 | 2024-07-30 | 177 | — | $0 | 45,851 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 3,657 | $24.21 | $88.5K | 33,565 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 3,630 | $23.08 | $83.8K | 29,908 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 2,748 | $26.06 | $71.6K | 33,114 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 4,878 | $25.02 | $122.0K | 30,366 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 3,828 | $24.21 | $92.7K | 25,488 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 3,799 | $23.08 | $87.7K | 21,660 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 2,559 | $26.06 | $66.7K | 39,661 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 4,544 | $25.02 | $113.7K | 37,102 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 3,565 | $24.21 | $86.3K | 32,558 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 3,538 | $23.08 | $81.7K | 28,993 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 2,625 | $26.06 | $68.4K | 40,851 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-07-01 | 2024-07-03 | 4,661 | $25.02 | $116.6K | 38,226 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-06-28 | 2024-07-02 | 2,964 | — | $0 | 45,674 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 22,000 | — | $0 | 22,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 14,545 | — | $0 | 14,545 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-06-11 | 2024-06-13 | 3,495 | — | $0 | 31,603 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 11,924,138 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion | 2024-06-10 | 2024-06-10 | 1,392,738 | — | $0 | 1,392,738 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-06-10 | 2024-06-10 | 17,861 | $17.00 | $303.6K | 17,861 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-06-10 | 2024-06-10 | 26,278 | $17.00 | $446.7K | 26,278 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-06-10 | 2024-06-10 | 25,455 | $17.00 | $432.7K | 25,455 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-06-10 | 2024-06-10 | 18,641 | $17.00 | $316.9K | 18,641 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2024-06-10 | 2024-06-10 | 470,589 | $17.00 | $8.00M | 1,863,327 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-04-26 | 2024-04-30 | 210 | — | $0 | 42,710 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 12,500 | $232.41 | $2.91M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 683 | $330.00 | $225.4K | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 1,372,441 | $330.00 | $452.91M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 8,025 | $330.00 | $2.65M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 32,500 | $330.00 | $10.72M | 990 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion deriv | 2024-01-30 | 2024-01-31 | 1,252,308 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | P Buy | 2024-01-30 | 2024-01-31 | 444,444 | $18.00 | $8.00M | 1,696,752 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | C Conversion | 2024-01-30 | 2024-01-31 | 1,252,308 | — | $0 | 1,252,308 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2024-01-26 | 2024-01-30 | 264 | $63.79 | $16.8K | 42,500 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2023-12-13 | 2023-12-22 | 644,000 | $58.75 | $37.84M | 0 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-10-27 | 2023-10-31 | 396 | $42.60 | $16.9K | 42,236 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-07-28 | 2023-08-01 | 328 | $48.48 | $15.9K | 41,840 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 4,255 | — | $0 | 4,255 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-06-30 | 2023-07-05 | 2,750 | — | $0 | 41,512 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 33,490 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2023-06-14 | 2023-06-20 | 8,025 | — | $0 | 8,025 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2023-06-14 | 2023-06-20 | 400,000 | — | $0 | 1,372,441 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 13,950 | — | $0 | 13,950 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-06-08 | 2023-06-09 | 2,330 | — | $0 | 28,108 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2023-05-25 | 2023-05-30 | 3,534 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2023-05-25 | 2023-05-30 | 3,534 | — | $0 | 38,762 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-04-14 | 2023-04-18 | 285 | $54.73 | $15.6K | 35,228 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 9,803 | — | $0 | 19,608 | SEC↗ |
| CINC CinCor Pharma, Inc. | D To issuer | 2023-02-24 | 2023-02-27 | 19,608 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-27 | 6,073,949 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2023-02-06 | 2023-02-08 | 285,714 | $7.00 | $2.00M | 3,467,156 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | S Sale | 2023-01-13 | 2023-01-17 | 6,027 | $199.90 | $1.20M | 0 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2023-01-13 | 2023-01-18 | 390 | $40.01 | $15.6K | 34,943 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2023-01-12 | 2023-01-17 | 6,027 | — | $0 | 6,027 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | J Other | 2023-01-12 | 2023-01-17 | 300,000 | — | $0 | 1,772,441 | SEC↗ |
| CINC CinCor Pharma, Inc. | S Sale | 2022-11-28 | 2023-02-27 | 6,000 | $14.32 | $85.9K | 0 | SEC↗ |
| NTRA Natera, Inc. | S Sale | 2022-11-16 | 2023-01-18 | 2,400 | $37.71 | $90.5K | 0 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2022-10-14 | 2022-10-18 | 344 | $45.42 | $15.6K | 34,553 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-11 | 2022-08-15 | 6,000 | $30.00 | $180.0K | 6,000 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-11 | 2022-08-15 | 500,000 | $30.00 | $15.00M | 6,073,949 | SEC↗ |
| CINC CinCor Pharma, Inc. | M Exercise deriv | 2022-08-05 | 2022-08-08 | 29,411 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | M Exercise deriv | 2022-08-05 | 2022-08-08 | 32,500 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | M Exercise | 2022-08-05 | 2022-08-08 | 29,411 | $13.60 | $400.0K | 29,411 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | M Exercise | 2022-08-05 | 2022-08-08 | 32,500 | $16.00 | $520.0K | 32,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-07-15 | 2022-07-19 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2022-07-08 | 2022-07-12 | 430 | $36.31 | $15.6K | 430 | SEC↗ |
| NTRA Natera, Inc. | A Award | 2022-07-08 | 2022-09-02 | 430 | — | $0 | 34,209 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-06-30 | 2022-07-01 | 48,062 | $122.27 | $5.88M | 2,048,280 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-06-30 | 2022-07-01 | 24,161 | $123.39 | $2.98M | 2,072,441 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-06-29 | 2022-07-01 | 6,832 | $124.73 | $852.2K | 1,991,089 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-06-29 | 2022-07-01 | 4,039 | $122.95 | $496.6K | 1,984,257 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-06-29 | 2022-07-01 | 27,777 | $121.99 | $3.39M | 1,980,218 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-06-29 | 2022-07-01 | 9,129 | $125.00 | $1.14M | 2,000,218 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-06-10 | 2022-06-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2022-05-27 | 2022-06-01 | 7,068 | — | $0 | 7,068 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2022-05-27 | 2022-06-01 | 3,534 | — | $0 | 3,534 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 1,307 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 1,307 | — | $0 | 33,779 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2022-04-01 | 2022-04-14 | 47 | $129.38 | $6.1K | 683 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award deriv | 2022-03-24 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2022-02-10 | 2022-02-14 | 266,666 | $15.00 | $4.00M | 3,181,442 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 4,275,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 13,571,428 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 5,248,949 | — | $0 | 5,248,949 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 325,000 | $16.00 | $5.20M | 5,573,949 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2022-01-07 | 2022-01-10 | 27,000 | — | $0 | 27,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2022-01-07 | 2022-02-11 | 27,000 | — | $0 | 27,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2021-09-29 | 2021-09-29 | 286,076 | $16.12 | $4.61M | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2021-09-28 | 2021-09-29 | 48,329 | $17.17 | $829.8K | 286,076 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2021-09-27 | 2021-09-29 | 100,150 | $18.06 | $1.81M | 334,405 | SEC↗ |
| NTRA Natera, Inc. | P Buy | 2021-07-22 | 2021-07-26 | 2,400 | $113.00 | $271.2K | 2,400 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 10,565,238 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | P Buy | 2021-07-02 | 2021-07-06 | 357,142 | $14.00 | $5.00M | 3,758,686 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 3,401,544 | — | $0 | 3,401,544 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2021-07-02 | 2021-07-07 | 636 | $117.80 | $74.9K | 636 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-23 | 8,500 | — | $0 | 8,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2021-05-28 | 2021-06-02 | 2,614 | — | $0 | 2,614 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2021-05-28 | 2021-06-02 | 1,307 | — | $0 | 1,307 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2021-05-28 | 2021-06-02 | 2,856 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2021-05-28 | 2021-06-02 | 2,856 | — | $0 | 32,472 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion deriv | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 727,272 | $11.00 | $8.00M | 2,914,776 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 450,000 | $20.00 | $9.00M | 2,754,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,200,228 | — | $0 | 2,304,437 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,104,209 | — | $0 | 1,104,209 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2021-01-11 | 2021-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2020-09-29 | 2020-10-01 | 950,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2020-09-29 | 2020-10-01 | 213,546 | — | $0 | 434,555 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2020-09-09 | 2020-09-11 | 4,557 | $73.75 | $336.1K | 1,952,441 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2020-09-08 | 2020-09-09 | 504 | $73.00 | $36.8K | 1,947,884 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 8,330 | $73.59 | $613.0K | 1,947,380 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 45,317 | $71.30 | $3.23M | 1,932,589 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 6,461 | $72.73 | $469.9K | 1,939,050 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 1,670 | $70.12 | $117.1K | 1,887,272 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2020-08-28 | 2020-09-01 | 221,009 | — | $0 | 221,009 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | J Other | 2020-08-28 | 2020-09-01 | 983,221 | — | $0 | 950,000 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 12,500,000 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 8,753,350 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 3,644,624 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion | 2020-08-11 | 2020-08-12 | 3,473,374 | — | $0 | 3,473,374 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | P Buy | 2020-08-11 | 2020-08-12 | 133,333 | $15.00 | $2.00M | 3,606,707 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 11,888,112 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,590,808 | — | $0 | 1,590,808 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 437,500 | $16.00 | $7.00M | 2,028,308 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 12,643,557 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 18,044,028 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 58,823 | $17.00 | $1000.0K | 1,515,073 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 599,988 | — | $0 | 1,456,250 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 856,262 | — | $0 | 856,262 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-06-23 | 2020-06-24 | 16,000 | — | $0 | 16,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 2,856 | — | $0 | 2,856 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2020-06-12 | 2020-06-16 | 5,712 | — | $0 | 5,712 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-06-02 | 2020-06-03 | 400,000 | $1.61 | $644.0K | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-06-01 | 2020-06-03 | 100,000 | $1.69 | $169.0K | 1,626,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $1750000.00 | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-01-15 | 2020-01-17 | 17,778 | — | $0 | 14,222 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2020-01-15 | 2020-01-17 | 8,000 | — | $0 | 8,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-01-15 | 2020-01-17 | 8,000 | $21.45 | $171.6K | 25,778 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2020-01-15 | 2020-01-17 | 17,778 | $11.16 | $198.4K | 17,778 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-01-12 | 2020-01-13 | 20,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-01-12 | 2020-01-13 | 20,000 | $12.37 | $247.4K | 70,086 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-14 | 11,169 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-14 | 11,169 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2020-01-10 | 2020-01-14 | 11,169 | $10.41 | $116.3K | 29,616 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2020-01-10 | 2020-01-14 | 11,169 | $11.80 | $131.8K | 18,447 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-01-09 | 2020-01-13 | 20,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-01-09 | 2020-01-13 | 29,994 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-01-09 | 2020-01-13 | 29,994 | $1.67 | $50.1K | 30,086 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-01-09 | 2020-01-13 | 20,000 | $10.05 | $201.0K | 50,086 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2019-11-25 | 2019-11-25 | 156,250 | $96.00 | $15.00M | 1,885,602 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-11-15 | 2019-11-19 | 150,000 | $36.75 | $5.51M | 2,671,856 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,090,909 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 2,709,659 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 750,000 | $12.00 | $9.00M | 3,083,712 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 2,333,712 | — | $0 | 2,333,712 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2019-10-30 | 2019-11-01 | 90,000 | $28.00 | $2.52M | 2,194,278 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion deriv | 2019-07-02 | 2019-07-02 | 792,602 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | P Buy | 2019-07-02 | 2019-07-02 | 700,000 | $16.00 | $11.20M | 1,729,352 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | C Conversion | 2019-07-02 | 2019-07-02 | 1,029,352 | — | $0 | 1,029,352 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-07-02 | 2019-07-02 | 160,000 | $22.61 | $3.62M | 1,933,221 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-06-28 | 2019-07-02 | 200,000 | $22.05 | $4.41M | 2,093,221 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2019-06-27 | 2019-07-01 | 32,500 | — | $0 | 32,500 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-06-20 | 2019-06-24 | 317,130 | $21.37 | $6.78M | 2,293,221 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2019-06-13 | 2019-06-17 | 5,703 | — | $0 | 5,703 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise deriv | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2019-05-24 | 2019-05-29 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ITRM Iterum Therapeutics plc | M Exercise | 2019-05-24 | 2019-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2019-05-22 | 2019-05-24 | 257,870 | $20.69 | $5.34M | 2,610,351 | SEC↗ |
| NTRA Natera, Inc. | M Exercise deriv | 2019-05-16 | 2019-11-27 | 7,278 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | M Exercise | 2019-05-16 | 2019-11-27 | 7,278 | — | $0 | 7,278 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,773,585 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 7,301,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,732,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 2,239,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 464,599 | — | $0 | 743,358 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 908,785 | — | $0 | 1,652,143 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 469,713 | — | $0 | 2,121,856 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 278,759 | — | $0 | 278,759 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-15 | 400,000 | $15.00 | $6.00M | 2,521,856 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2019-04-12 | 2019-04-16 | 7,278 | — | $0 | 7,278 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2019-01-11 | 2019-01-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,446,904 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 9,502,249 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 359,267 | — | $0 | 359,267 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 337,724 | $15.00 | $5.07M | 1,180,178 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 458,425 | — | $0 | 842,454 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | P Buy | 2018-09-21 | 2018-09-25 | 500,000 | $16.00 | $8.00M | 2,104,278 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 625,482 | — | $0 | 625,482 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 270,000 | $17.00 | $4.59M | 2,038,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 167,537 | — | $0 | 1,768,208 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 453,954 | — | $0 | 1,600,671 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 521,235 | — | $0 | 1,146,717 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2018-09-14 | 2019-04-16 | 5,785 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2018-09-14 | 2018-09-18 | 11,169 | — | $0 | 11,169 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2018-09-14 | 2018-09-18 | 5,785 | — | $0 | 5,785 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2018-08-29 | 2018-08-31 | 25,000 | $20.50 | $512.5K | 2,868,221 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 996,854 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 500,000 | $13.00 | $6.50M | 1,726,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 721,408 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2018-05-24 | 2018-05-29 | 6,154 | — | $0 | 6,154 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-21 | 15,000 | $10.15 | $152.3K | 15,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2017-06-09 | 2017-06-13 | 11,169 | — | $0 | 11,169 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 724,788 | $1.39 | $1.01M | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 12,528 | $1.39 | $17.4K | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 13,367 | $1.39 | $18.6K | 224,845 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 28,847 | — | $0 | 28,847 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 20,548 | — | $0 | 20,548 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NTRA Natera, Inc. | A Award deriv | 2016-06-10 | 2016-06-14 | 11,169 | — | $0 | 11,169 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2016-05-24 | 2016-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2016-03-11 | 2016-03-15 | 541,343 | $7.30 | $3.95M | 2,852,711 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,424,242 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,063,107 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,000,000 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2015-10-13 | 2015-10-13 | 409,090 | $11.00 | $4.50M | 2,289,480 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion | 2015-10-13 | 2015-10-13 | 1,880,390 | — | $0 | 1,880,390 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 2,473,118 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-06 | 857,142 | $7.00 | $6.00M | 2,974,811 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-06 | 289,841 | — | $0 | 2,117,669 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 1,807,703 | — | $0 | 1,807,703 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-08 | 450,000 | $11.00 | $4.95M | 2,257,703 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 53,665 | $8.60 | $461.5K | 2,311,368 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion deriv | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 0 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 1,244,269 | — | $0 | 1,244,269 | SEC↗ |
| MIRN Mirna Therapeutics, Inc. | C Conversion | 2015-10-05 | 2015-10-06 | 583,559 | — | $0 | 1,827,828 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-10 | 2015-07-14 | 38,867,180 | $0.15 | $5.83M | 38,867,180 | SEC↗ |
| NTRA Natera, Inc. | C Conversion deriv | 2015-07-08 | 2015-07-09 | 1,175,280 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | C Conversion deriv | 2015-07-08 | 2015-07-09 | 1,175,280 | — | $0 | 0 | SEC↗ |
| NTRA Natera, Inc. | C Conversion | 2015-07-08 | 2015-07-09 | 1,175,280 | — | $0 | 1,550,280 | SEC↗ |
| NTRA Natera, Inc. | P Buy | 2015-07-08 | 2015-07-09 | 175,000 | $18.00 | $3.15M | 375,000 | SEC↗ |
| NTRA Natera, Inc. | P Buy | 2015-07-08 | 2015-07-09 | 175,000 | $18.00 | $3.15M | 375,000 | SEC↗ |
| NTRA Natera, Inc. | C Conversion | 2015-07-08 | 2015-07-09 | 1,175,280 | — | $0 | 1,550,280 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 17,358 | — | $0 | 17,358 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 23,144 | — | $0 | 23,144 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 40,500 | — | $0 | 40,500 | SEC↗ |
| NTRA Natera, Inc. | P Buy | 2015-07-02 | 2015-07-07 | 200,000 | $22.81 | $4.56M | 200,000 | SEC↗ |
| NTRA Natera, Inc. | P Buy | 2015-07-02 | 2015-07-07 | 200,000 | $22.81 | $4.56M | 200,000 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 14,968,722 | — | $0 | 0 | SEC↗ |